Halis Akturk News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Halis akturk. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Halis Akturk Today - Breaking & Trending Today

HCPLive - Clinical news for connected physicians

HCPLive is a comprehensive clinical news and information portal that provides physicians with up-to-date specialty and disease-specific resources designed to help them provide better care to patients. At HCPLive, you will find breaking news, video interviews with physician experts, in-depth conference coverage, finance and practice management updates, insight and analysis from physician contributors, and more. ....

Tim Smith , Connor Iapoce , Halis Akturk , Patrick Campbell , Kevin Kunzmann , Novo Nordisk , Internal Medicine , Primary Care , Rare Disease , Infectious Disease ,

Breaking Down Hyperglycemic Ketosis-Cannabis Hyperemesis Syndrome in Type 1 Diabetes, with Halis Akturk, MD

At ADCES 2023, Halis Akturk, MD, presented data calling attention to the risk of hyperglycemic ketosis-cannabis hyperemesis syndrome in people with type 1 diabetes. ....

United States , Halis Akturk , Pediatr Pulmonol , Campbellp Robert , Barbara Davis Center , University Of Colorado , Blood Glucose , Diabetes Care , Tandem Diabetes , Diabetic Ketoacidosis , Hyperglycemic Ketosis Due , Cannabis Hyperemesis Syndrome , Adults With Type ,

JDRF Joins Diabetes Professionals at the American Diabetes Association 83rd Scientific Sessions to Celebrate Advancements in Type 1 Diabetes Research

/PRNewswire/ JDRF, the leading global type 1 diabetes (T1D) research and advocacy organization, joined thousands within the diabetes community at the. ....

United States , Farooq Syed , Aaron Kowalski , Halis Akturk , Schafer Boeder , Martin Thelin , Trevor Reichman , Doug Melton , Edwin Liu , Sanjoy Dutta , San Diego Convention Center , Vertex Pharmaceuticals , D Fund In Semma Therapeutics , American Diabetes Association , Scientific Sessions , Semma Therapeutics ,